Proteomic analysis of secreted proteins from skeletal muscle cells during differentiation

EuPA Open Proteomics

Volumn 5, Issue , 2014, Pages 1-9

  Ojima, Koichi ^a   Oe, Mika ^a   Nakajima, Ikuyo ^a   Shibata, Masahiro ^b   Chikuni, Koichi ^a   Muroya, Susumu ^a   Nishimura, Takanori ^c  

^a FOOD RESEARCH INSTITUTE   (Japan)

^b NATIONAL AGRICULTURAL RESEARCH CENTER FOR WESTERN REGION   (Japan)

^c HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Differentiation; Growth factor; Myokine; Proteome; Skeletal muscle

Indexed keywords

EID: 84949129837     PISSN: 22129685     EISSN: 22129685     Source Type: Journal    
DOI: 10.1016/j.euprot.2014.08.001     Document Type: Article

References (55)

1. Stewart C.E., Rotwein P. Growth, differentiation, and survival: multiple physiological functions for insulin-like growth factors. Physiol Rev 1996, 76:1005-1026.
2. Jacquemin V., Furling D., Bigot A., Butler-Browne G.S., Mouly V. IGF-1 induces human myotube hypertrophy by increasing cell recruitment. Exp Cell Res 2004, 299:148-158.
3. Coleman M.E., DeMayo F., Yin K.C., Lee H.M., Geske R., Montgomery C., et al. Myogenic vector expression of insulin-like growth factor I stimulates muscle cell differentiation and myofiber hypertrophy in transgenic mice. J Biol Chem 1995, 270:12109-12116.
4. Barton-Davis E.R., Shoturma D.I., Musaro A., Rosenthal N., Sweeney H.L. Viral mediated expression of insulin-like growth factor I blocks the aging-related loss of skeletal muscle function. Proc Natl Acad Sci U S A 1998, 95:15603-15607.
5. Tatsumi R., Anderson J.E., Nevoret C.J., Halevy O., Allen R.E. HGF/SF is present in normal adult skeletal muscle and is capable of activating satellite cells. Dev Biol 1998, 194:114-128.
6. McCroskery S., Thomas M., Maxwell L., Sharma M., Kambadur R. Myostatin negatively regulates satellite cell activation and self-renewal. J Cell Biol 2003, 162:1135-1147.
7. McPherron A.C., Lawler A.M., Lee S.J. Regulation of skeletal muscle mass in mice by a new TGF-beta superfamily member. Nature 1997, 387:83-90.
8. Bogdanovich S., Krag T.O., Barton E.R., Morris L.D., Whittemore L.A., Ahima R.S., et al. Functional improvement of dystrophic muscle by myostatin blockade. Nature 2002, 420:418-421.
9. Febbraio M.A., Pedersen B.K. Contraction-induced myokine production and release: is skeletal muscle an endocrine organ?. Exerc Sport Sci Rev 2005, 33:114-119.
10. Steensberg A., van Hall G., Osada T., Sacchetti M., Saltin B., Klarlund Pedersen B. Production of interleukin-6 in contracting human skeletal muscles can account for the exercise-induced increase in plasma interleukin-6. J Physiol 2000, 529(Pt 1):237-242.
11. Weigert C., Brodbeck K., Staiger H., Kausch C., Machicao F., Haring H.U., et al. Palmitate, but not unsaturated fatty acids, induces the expression of interleukin-6 in human myotubes through proteasome-dependent activation of nuclear factor-kappaB. J Biol Chem 2004, 279:23942-23952.
12. Scheler M., Irmler M., Lehr S., Hartwig S., Staiger H., Al-Hasani H., et al. Cytokine response of primary human myotubes in an in vitro exercise model. Am J Physiol Cell Physiol 2013, 305:C877-C886.
13. Pedersen B.K., Akerstrom T.C., Nielsen A.R., Fischer C.P. Role of myokines in exercise and metabolism. J Appl Physiol 1985, 103(2007):1093-1098.
14. Ojima K., Uezumi A., Miyoshi H., Masuda S., Morita Y., Fukase A., et al. Mac-1(low) early myeloid cells in the bone marrow-derived SP fraction migrate into injured skeletal muscle and participate in muscle regeneration. Biochem Biophys Res Commun 2004, 321:1050-1061.
15. Ojima K., Kawabata Y., Nakao H., Nakao K., Doi N., Kitamura F., et al. Dynamic distribution of muscle-specific calpain in mice has a key role in physical-stress adaptation and is impaired in muscular dystrophy. J Clin Invest 2010, 120:2672-2683.
16. Cho M., Webster S.G., Blau H.M. Evidence for myoblast-extrinsic regulation of slow myosin heavy chain expression during muscle fiber formation in embryonic development. J Cell Biol 1993, 121:795-810.
17. +-dependent protease. J Biol Chem 2010, 285:22986-22998.
18. Petersen T.N., Brunak S., von Heijne G., Nielsen H. SignalP 4.0: discriminating signal peptides from transmembrane regions. Nat Methods 2011, 8:785-786.
19. Bendtsen J.D., Jensen L.J., Blom N., Von Heijne G., Brunak S. Feature-based prediction of non-classical and leaderless protein secretion. Protein Eng Des Sel 2004, 17:349-356.
20. Mathivanan S., Fahner C.J., Reid G.E., Simpson R.J. ExoCarta 2012: database of exosomal proteins, RNA and lipids. Nucleic Acids Res 2012, 40:D1241-D1244.
21. De Winter F., Vo T., Stam F.J., Wisman L.A., Bar P.R., Niclou S.P., et al. The expression of the chemorepellent Semaphorin 3A is selectively induced in terminal Schwann cells of a subset of neuromuscular synapses that display limited anatomical plasticity and enhanced vulnerability in motor neuron disease. Mol Cell Neurosci 2006, 32:102-117.
22. Suzuki T., Do M.K., Sato Y., Ojima K., Hara M., Mizunoya W., et al. Comparative analysis of semaphorin 3A in soleus and EDL muscle satellite cells in vitro toward understanding its role in modulating myogenin expression. Int J Biochem Cell Biol 2013, 45:476-482.
23. Tatsumi R., Sankoda Y., Anderson J.E., Sato Y., Mizunoya W., Shimizu N., et al. Possible implication of satellite cells in regenerative motoneuritogenesis: HGF upregulates neural chemorepellent Sema3A during myogenic differentiation. Am J Physiol Cell Physiol 2009, 297:C238-C252.
24. Henningsen J., Rigbolt K.T., Blagoev B., Pedersen B.K., Kratchmarova I. Dynamics of the skeletal muscle secretome during myoblast differentiation. Mol Cell Proteomics 2010, 9:2482-2496.
25. Rende M., Brizi E., Donato R., Provenzano C., Bruno R., Mizisin A.P., et al. Prosaposin is immunolocalized to muscle and prosaptides promote myoblast fusion and attenuate loss of muscle mass after nerve injury. Muscle Nerve 2001, 24:799-808.
26. Palumbo R., Sampaolesi M., De Marchis F., Tonlorenzi R., Colombetti S., Mondino A., et al. Extracellular HMGB1, a signal of tissue damage, induces mesoangioblast migration and proliferation. J Cell Biol 2004, 164:441-449.
27. Georgiadis V., Stewart H.J., Pollard H.J., Tavsanoglu Y., Prasad R., Horwood J., et al. Lack of galectin-1 results in defects in myoblast fusion and muscle regeneration. Dev Dyn 2007, 236:1014-1024.
28. Palumbo R., Bianchi M.E. High mobility group box 1 protein, a cue for stem cell recruitment. Biochem Pharmacol 2004, 68:1165-1170.
29. De Mori R., Straino S., Di Carlo A., Mangoni A., Pompilio G., Palumbo R., et al. Multiple effects of high mobility group box protein 1 in skeletal muscle regeneration. Arterioscler Thromb Vasc Biol 2007, 27:2377-2383.
30. Jorgensen L.H., Petersson S.J., Sellathurai J., Andersen D.C., Thayssen S., Sant D.J., et al. Secreted protein acidic and rich in cysteine (SPARC) in human skeletal muscle. J Histochem Cytochem 2009, 57:29-39.
31. Cho W.J., Kim E.J., Lee S.J., Kim H.D., Shin H.J., Lim W.K. Involvement of SPARC in in vitro differentiation of skeletal myoblasts. Biochem Biophys Res Commun 2000, 271:630-634.
32. Nakamura K., Nakano S., Miyoshi T., Yamanouchi K., Matsuwaki T., Nishihara M. Age-related resistance of skeletal muscle-derived progenitor cells to SPARC may explain a shift from myogenesis to adipogenesis. Aging (Albany, NY) 2012, 4:40-48.
33. Kos K., Wilding J.P. SPARC: a key player in the pathologies associated with obesity and diabetes. Nat Rev Endocrinol 2010, 6:225-235.
34. Nie J., Sage E.H. SPARC inhibits adipogenesis by its enhancement of beta-catenin signaling. J Biol Chem 2009, 284:1279-1290.
35. Uezumi A., Fukada S., Yamamoto N., Takeda S., Tsuchida K. Mesenchymal progenitors distinct from satellite cells contribute to ectopic fat cell formation in skeletal muscle. Nat Cell Biol 2010, 12:143-152.
36. Peterson J.M., Wei Z., Wong G.W. C1q/TNF-related protein-3 (CTRP3), a novel adipokine that regulates hepatic glucose output. J Biol Chem 2010, 285:39691-39701.
37. Kopp A., Bala M., Weigert J., Buchler C., Neumeier M., Aslanidis C., et al. Effects of the new adiponectin paralogous protein CTRP-3 and of LPS on cytokine release from monocytes of patients with type 2 diabetes mellitus. Cytokine 2010, 49:51-57.
38. Svestak M., Sporova L., Hejduk P., Lacnak B., Stejskal D. Collagenous repeat-containing sequence of 26kDa protein - a newly discovered adipokine - sensu lato - a minireview. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub 2010, 154:199-202.
39. Thirant C., Galan-Moya E.M., Dubois L.G., Pinte S., Chafey P., Broussard C., et al. Differential proteomic analysis of human glioblastoma and neural stem cells reveals HDGF as a novel angiogenic secreted factor. Stem Cells 2012, 30:845-853.
40. Zhang J.L., Chen G.W., Liu Y.C., Wang P.Y., Wang X., Wan Y.L., et al. Secreted protein acidic and rich in cysteine (SPARC) suppresses angiogenesis by down-regulating the expression of VEGF and MMP-7 in gastric cancer. PLOS ONE 2012, 7:e44618.
41. Velleman S.G., Song Y., Shin J., McFarland D.C. Modulation of turkey myogenic satellite cell differentiation through the shedding of glypican-1. Comp Biochem Physiol A Mol Integr Physiol 2013, 164:36-43.
42. Sandstrom J., Karlsson K., Edlund T., Marklund S.L. Heparin-affinity patterns and composition of extracellular superoxide dismutase in human plasma and tissues. Biochem J 1993, 294(Pt 3):853-857.
43. Schaefer L., Iozzo R.V. Biological functions of the small leucine-rich proteoglycans: from genetics to signal transduction. J Biol Chem 2008, 283:21305-21309.
44. Schonherr E., Witsch-Prehm P., Harrach B., Robenek H., Rauterberg J., Kresse H. Interaction of biglycan with type I collagen. J Biol Chem 1995, 270:2776-2783.
45. Casar J.C., McKechnie B.A., Fallon J.R., Young M.F., Brandan E. Transient up-regulation of biglycan during skeletal muscle regeneration: delayed fiber growth along with decorin increase in biglycan-deficient mice. Dev Biol 2004, 268:358-371.
46. Shefer G., Benayahu D. SVEP1 is a novel marker of activated pre-determined skeletal muscle satellite cells. Stem Cell Rev 2010, 6:42-49.
47. Sato-Nishiuchi R., Nakano I., Ozawa A., Sato Y., Takeichi M., Kiyozumi D., et al. Polydom/SVEP1 is a ligand for integrin alpha9beta1. J Biol Chem 2012, 287:25615-25630.
48. Lafuste P., Sonnet C., Chazaud B., Dreyfus P.A., Gherardi R.K., Wewer U.M., et al. ADAM12 and alpha9beta1 integrin are instrumental in human myogenic cell differentiation. Mol Biol Cell 2005, 16:861-870.
49. Nishimura T., Nakamura K., Kishioka Y., Kato-Mori Y., Wakamatsu J., Hattori A. Inhibition of matrix metalloproteinases suppresses the migration of skeletal muscle cells. J Muscle Res Cell Motil 2008, 29:37-44.
50. Haurigot V., Villacampa P., Ribera A., Bosch A., Ramos D., Ruberte J., et al. Long-term retinal PEDF overexpression prevents neovascularization in a murine adult model of retinopathy. PLOS ONE 2012, 7:e41511.
51. Chan X.C., McDermott J.C., Siu K.W. Identification of secreted proteins during skeletal muscle development. J Proteome Res 2007, 6:698-710.
52. Yoon J.H., Yea K., Kim J., Choi Y.S., Park S., Lee H., et al. Comparative proteomic analysis of the insulin-induced L6 myotube secretome. Proteomics 2009, 9:51-60.
53. Wang J., Walsh K. Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 1996, 273:359-361.
54. Kravchenko I.V., Furalyov V.A., Popov V.O. Stimulation of mechano-growth factor expression by myofibrillar proteins in murine myoblasts and myotubes. Mol Cell Biochem 2012, 363:347-355.
55. Bischoff R. A satellite cell mitogen from crushed adult muscle. Dev Biol 1986, 115:140-147.